New Delhi: Subsidiary of Jubilant Farmova Jubilant Pharma will sell its entire 25.8% stake in US-based SoFi Biosciences for $139.4 million. Singapore-based Jubilant Pharma invested $25 million in SoFi in November 2020, a company statement said.
Sophie is engaged in the development and delivery of molecular diagnostics and therapeutics (theranostics). It has radiopharmaceutical production and distribution networks, mature contract manufacturing services and high-value therapeutic intellectual property. It has now entered into a definitive merger agreement with some private equity funds.
Sophie is engaged in the development and delivery of molecular diagnostics and therapeutics (theranostics). It has radiopharmaceutical production and distribution networks, mature contract manufacturing services and high-value therapeutic intellectual property. It has now entered into a definitive merger agreement with some private equity funds.
